| 000 | 01882 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250514063912.0 | ||
| 264 | 0 | _c20030424 | |
| 008 | 200304s 0 0 eng d | ||
| 022 | _a0004-3591 | ||
| 024 | 7 |
_a10.1002/art.10885 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aQuartier, Pierre | |
| 245 | 0 | 0 |
_aEfficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. _h[electronic resource] |
| 260 |
_bArthritis and rheumatism _cApr 2003 |
||
| 300 |
_a1093-101 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aArthralgia |
| 650 | 0 | 4 |
_aArthritis, Juvenile _xclassification |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHealth Status |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xtherapeutic use |
| 650 | 0 | 4 |
_aJoints _xphysiopathology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xtherapeutic use |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xtherapeutic use |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aTaupin, Pierre | |
| 700 | 1 | _aBourdeaut, Franck | |
| 700 | 1 | _aLemelle, Irène | |
| 700 | 1 | _aPillet, Pascal | |
| 700 | 1 | _aBost, Michel | |
| 700 | 1 | _aSibilia, Jean | |
| 700 | 1 | _aKoné-Paut, Isabelle | |
| 700 | 1 | _aGandon-Laloum, Sylvie | |
| 700 | 1 | _aLeBideau, Marc | |
| 700 | 1 | _aBader-Meunier, Brigitte | |
| 700 | 1 | _aMouy, Richard | |
| 700 | 1 | _aDebré, Marianne | |
| 700 | 1 | _aLandais, Paul | |
| 700 | 1 | _aPrieur, Anne-Marie | |
| 773 | 0 |
_tArthritis and rheumatism _gvol. 48 _gno. 4 _gp. 1093-101 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/art.10885 _zAvailable from publisher's website |
| 999 |
_c12479580 _d12479580 |
||